NPORT-EX 2 c10743bnymellons-august20231.htm Untitled Document

STATEMENT OF INVESTMENTS
BNY Mellon Sustainable U.S. Equity Fund, Inc.

August 31, 2023 (Unaudited)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 98.0%

     

Banks - 2.9%

     

JPMorgan Chase & Co.

   

81,116

 

 11,869,704

 

Capital Goods - 4.2%

     

Ingersoll Rand, Inc.

   

129,074

 

8,984,841

 

Trane Technologies PLC

   

38,019

 

7,803,780

 
    

16,788,621

 

Commercial & Professional Services - 1.6%

     

Waste Management, Inc.

   

40,517

 

 6,352,255

 

Consumer Discretionary Distribution - 5.2%

     

Amazon.com, Inc.

   

152,846

a 

 21,094,276

 

Consumer Durables & Apparel - 2.3%

     

NIKE, Inc., Cl. B

   

90,181

 

 9,172,310

 

Consumer Staples Distribution - 2.8%

     

Costco Wholesale Corp.

   

20,566

 

 11,296,492

 

Financial Services - 5.2%

     

Mastercard, Inc., Cl. A

   

34,053

 

14,051,630

 

The Goldman Sachs Group, Inc.

   

20,722

 

6,790,807

 
    

20,842,437

 

Food, Beverage & Tobacco - 4.3%

     

Darling Ingredients, Inc.

   

98,894

a 

6,107,693

 

PepsiCo, Inc.

   

62,531

 

11,125,516

 
    

17,233,209

 

Health Care Equipment & Services - 6.5%

     

Boston Scientific Corp.

   

208,611

a 

11,252,477

 

Edwards Lifesciences Corp.

   

90,191

a 

6,896,906

 

The Cooper Companies, Inc.

   

22,029

 

8,150,510

 
    

26,299,893

 

Insurance - 4.2%

     

Chubb Ltd.

   

40,521

 

8,139,453

 

The Progressive Corp.

   

65,812

 

8,783,928

 
    

16,923,381

 

Materials - 4.0%

     

Albemarle Corp.

   

30,307

 

6,022,304

 

CF Industries Holdings, Inc.

   

61,189

 

4,715,836

 

Ecolab, Inc.

   

28,798

 

5,293,360

 
    

16,031,500

 

Media & Entertainment - 5.0%

     

Alphabet, Inc., Cl. A

   

149,721

a 

 20,387,509

 

Pharmaceuticals, Biotechnology & Life Sciences - 10.1%

     

AbbVie, Inc.

   

66,755

 

9,810,315

 


STATEMENT OF INVESTMENTS (Unaudited) (continued)

        
 

Description

   

Shares

 

Value ($)

 

Common Stocks - 98.0% (continued)

     

Pharmaceuticals, Biotechnology & Life Sciences - 10.1% (continued)

     

Danaher Corp.

   

40,266

 

10,670,490

 

Eli Lilly & Co.

   

26,371

 

14,614,808

 

Zoetis, Inc.

   

29,130

 

5,549,556

 
    

40,645,169

 

Semiconductors & Semiconductor Equipment - 7.8%

     

Applied Materials, Inc.

   

45,918

 

7,014,434

 

Enphase Energy, Inc.

   

22,802

a 

2,885,137

 

NVIDIA Corp.

   

33,910

 

16,736,281

 

Texas Instruments, Inc.

   

28,908

 

4,858,278

 
    

31,494,130

 

Software & Services - 17.9%

     

Accenture PLC, Cl. A

   

33,270

 

10,771,828

 

Akamai Technologies, Inc.

   

57,082

a 

5,998,747

 

Ansys, Inc.

   

17,680

a 

5,637,622

 

Intuit, Inc.

   

20,742

 

11,238,223

 

Microsoft Corp.

   

91,652

 

30,039,860

 

Roper Technologies, Inc.

   

16,940

 

8,454,076

 
    

72,140,356

 

Technology Hardware & Equipment - 9.0%

     

Apple, Inc.

   

157,820

 

29,649,643

 

TE Connectivity Ltd.

   

50,897

 

6,738,254

 
    

36,387,897

 

Transportation - 1.6%

     

Norfolk Southern Corp.

   

31,092

 

 6,374,171

 

Utilities - 3.4%

     

CMS Energy Corp.

   

111,466

 

6,263,275

 

NextEra Energy, Inc.

   

110,988

 

7,413,998

 
    

13,677,273

 

Total Common Stocks (cost $264,001,186)

   

395,010,583

 
  

1-Day
Yield (%)

     

Investment Companies - 1.7%

     

Registered Investment Companies - 1.7%

     

Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional Shares
(cost $6,960,385)

 

5.41

 

6,960,385

b 

 6,960,385

 

Total Investments (cost $270,961,571)

 

99.7%

 

401,970,968

 

Cash and Receivables (Net)

 

.3%

 

1,344,123

 

Net Assets

 

100.0%

 

403,315,091

 

a Non-income producing security.

b Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company’s prospectus.


The following is a summary of the inputs used as of August 31, 2023 in valuing the fund’s investments:

       
 

Level 1-Unadjusted Quoted Prices

Level 2- Other Significant Observable Inputs

 

Level 3-Significant Unobservable Inputs

Total

 

Assets ($) 

  

Investments in Securities:

  

Equity Securities - Common Stocks

395,010,583

-

 

-

395,010,583

 

Investment Companies

6,960,385

-

 

-

6,960,385

 

 See Statement of Investments for additional detailed categorizations, if any.


The Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) is the exclusive reference of authoritative U.S. generally accepted accounting principles (“GAAP”) recognized by the FASB to be applied by nongovernmental entities. Rules and interpretive releases of the SEC under authority of federal laws are also sources of authoritative GAAP for SEC registrants. The fund is an investment company and applies the accounting and reporting guidance of the FASB ASC Topic 946 Financial Services-Investment Companies. The fund’s financial statements are prepared in accordance with GAAP, which may require the use of management estimates and assumptions. Actual results could differ from those estimates.

The fair value of a financial instrument is the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (i.e., the exit price). GAAP establishes a fair value hierarchy that prioritizes the inputs of valuation techniques used to measure fair value. This hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

Additionally, GAAP provides guidance on determining whether the volume and activity in a market has decreased significantly and whether such a decrease in activity results in transactions that are not orderly. GAAP requires enhanced disclosures around valuation inputs and techniques used during annual and interim periods.

Various inputs are used in determining the value of the fund’s investments relating to fair value measurements. These inputs are summarized in the three broad levels listed below:

Level 1—unadjusted quoted prices in active markets for identical investments.

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.).

Level 3—significant unobservable inputs (including the fund’s own assumptions in determining the fair value of investments).

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the fund’s investments are as follows:

The fund’s Board of Directors (the “Board”) has designated the Adviser as the fund’s valuation designee to make all fair value determinations with respect to the fund’s portfolio investments, subject to the Board’s oversight and pursuant to Rule 2a-5 under the Act.


Investments in equity securities are valued at the last sales price on the securities exchange or national securities market on which such securities are primarily traded. Securities listed on the National Market System for which market quotations are available are valued at the official closing price or, if there is no official closing price that day, at the last sales price. For open short positions, asked prices are used for valuation purposes. Bid price is used when no asked price is available. Registered investment companies that are not traded on an exchange are valued at their net asset value. All of the preceding securities are generally categorized within Level 1 of the fair value hierarchy.

Securities not listed on an exchange or the national securities market, or securities for which there were no transactions, are valued at the average of the most recent bid and asked prices. U.S. Treasury Bills are valued at the mean price between quoted bid prices and asked prices by an independent pricing service (the “Service”) approved by the Board Members (“Board”). These securities are generally categorized within Level 2 of the fair value hierarchy.The Service’s procedures are reviewed by BNY Mellon under the general supervision of the Board.

Fair valuing of securities may be determined with the assistance of a pricing service using calculations based on indices of domestic securities and other appropriate indicators, such as prices of relevant American Depository Receipts and futures. Utilizing these techniques may result in transfers between Level 1 and Level 2 of the fair value hierarchy.

When market quotations or official closing prices are not readily available, or are determined not to accurately reflect fair value, such as when the value of a security has been significantly affected by events after the close of the exchange or market on which the security is principally traded (for example, a foreign exchange or market), but before the fund calculates its net asset value, the fund may value these investments at fair value as determined in accordance with the procedures approved by the Board. Certain factors may be considered when fair valuing investments such as: fundamental analytical data, the nature and duration of restrictions on disposition, an evaluation of the forces that influence the market in which the securities are purchased and sold, and public trading in similar securities of the issuer or comparable issuers. These securities are either categorized within Level 2 or 3 of the fair value hierarchy depending on the relevant inputs used.

For securities where observable inputs are limited, assumptions about market activity and risk are used and such securities are generally categorized within Level 3 of the fair value hierarchy.

At August 31, 2023, accumulated net unrealized appreciation on investments was $131,009,397, consisting of $141,936,800 gross unrealized appreciation and $10,927,403 gross unrealized depreciation.


At August 31, 2023, the cost of investments for federal income tax purposes was substantially the same as the cost for financial reporting purposes (see the Statement of Investments).

Additional investment related disclosures are hereby incorporated by reference to the annual and semi-annual reports previously filed with the SEC on Form N-CSR.